120 related articles for article (PubMed ID: 1865329)
1. Pharmacokinetics of acebutolol enantiomers in humans.
Piquette-Miller M; Foster RT; Kappagoda CT; Jamali F
J Pharm Sci; 1991 Apr; 80(4):313-6. PubMed ID: 1865329
[TBL] [Abstract][Full Text] [Related]
2. Effect of aging on the pharmacokinetics of acebutolol enantiomers.
Piquette-Miller M; Foster RT; Kappagoda CT; Jamali F
J Clin Pharmacol; 1992 Feb; 32(2):148-56. PubMed ID: 1613125
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of single oral and multiple intravenous and oral administration of acebutolol enantiomers in a rat model.
Mostafavi SA; Foster RT
Biopharm Drug Dispos; 1998 Oct; 19(7):425-31. PubMed ID: 9818708
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of acebutolol enantiomers after intravenous administration of racemate in a rat model: a dosing range comparison.
Mostafavi SA; Foster RT
Biopharm Drug Dispos; 1997 Jul; 18(5):397-408. PubMed ID: 9210978
[TBL] [Abstract][Full Text] [Related]
5. Effect of adjuvant arthritis on the disposition of acebutolol enantiomers in rats.
Piquette-Miller M; Jamali F
Agents Actions; 1992 Nov; 37(3-4):290-6. PubMed ID: 1295378
[TBL] [Abstract][Full Text] [Related]
6. Influence of cimetidine co-administration on the pharmacokinetics of acebutolol enantiomers and its metabolite diacetolol in a rat model: the effect of gastric pH on double-peak phenomena.
Mostafavi SA; Foster RT
Int J Pharm; 2003 Apr; 255(1-2):81-6. PubMed ID: 12672604
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and multiple peaking of acebutolol enantiomers in rats.
Piquette-Miller M; Jamali F
Biopharm Drug Dispos; 1997 Aug; 18(6):543-56. PubMed ID: 9267686
[TBL] [Abstract][Full Text] [Related]
8. Preliminary study of the disposition in man of acebutolol and its metabolite, diacetolol, using a new stereoselective hplc method.
Sankey MG; Gulaid A; Kaye CM
J Pharm Pharmacol; 1984 Apr; 36(4):276-7. PubMed ID: 6144783
[TBL] [Abstract][Full Text] [Related]
9. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
Kirch W; Köhler H; Berggren G; Braun W
Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
[TBL] [Abstract][Full Text] [Related]
10. Enantioselective high performance liquid chromatographic assay of acebutolol and its active metabolite diacetolol in human serum.
Szymura-Oleksiak J; Walczak M; Bojarski J; Aboul-Enein HY
Chirality; 1999; 11(4):267-71. PubMed ID: 10224653
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of sotalol enantiomers in humans.
Carr RA; Foster RT; Lewanczuk RZ; Hamilton PG
J Clin Pharmacol; 1992 Dec; 32(12):1105-9. PubMed ID: 1487548
[TBL] [Abstract][Full Text] [Related]
12. Using supported liquid extraction together with cellobiohydrolase chiral stationary phases-based liquid chromatography with tandem mass spectrometry for enantioselective determination of acebutolol and its active metabolite diacetolol in spiked human plasma.
Jiang H; Randlett C; Junga H; Jiang X; Ji QC
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):173-80. PubMed ID: 19109073
[TBL] [Abstract][Full Text] [Related]
13. Use of pseudoracemic nitrendipine to elucidate the metabolic steps responsible for stereoselective disposition of nitrendipine enantiomers.
Mast V; Fischer C; Mikus G; Eichelbaum M
Br J Clin Pharmacol; 1992 Jan; 33(1):51-9. PubMed ID: 1540491
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective pharmacokinetics of flurbiprofen in humans and rats.
Jamali F; Berry BW; Tehrani MR; Russell AS
J Pharm Sci; 1988 Aug; 77(8):666-9. PubMed ID: 3210154
[TBL] [Abstract][Full Text] [Related]
15. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of reboxetine enantiomers in the dog.
Frigerio E; Benecchi A; Brianceschi G; Pellizzoni C; Poggesi I; Strolin Benedetti M; Dostert P
Chirality; 1997; 9(3):303-6. PubMed ID: 9176997
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective pharmacokinetics and metabolism of the enantiomers of cyclophosphamide. Preliminary results in humans and rabbits.
Holm KA; Kindberg CG; Stobaugh JF; Slavik M; Riley CM
Biochem Pharmacol; 1990 Apr; 39(8):1375-84. PubMed ID: 2322319
[TBL] [Abstract][Full Text] [Related]
18. Assay and disposition of carvedilol enantiomers in humans and monkeys: evidence of stereoselective presystemic metabolism.
Fujimaki M; Murakoshi Y; Hakusui H
J Pharm Sci; 1990 Jul; 79(7):568-72. PubMed ID: 1975840
[TBL] [Abstract][Full Text] [Related]
19. Disposition of flurbiprofen in man: influence of stereochemistry and age.
Patel BK; Jackson SH; Swift CG; Hutt AJ
Xenobiotica; 2003 Oct; 33(10):1043-57. PubMed ID: 14555340
[TBL] [Abstract][Full Text] [Related]
20. Stereospecific high-performance liquid chromatographic assay of acebutolol in human plasma and urine.
Piquette-Miller M; Foster RT; Pasutto FM; Jamali F
J Chromatogr; 1990 Mar; 526(1):129-37. PubMed ID: 2341525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
